Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
1.68
Dollar change
-0.01
Percentage change
-0.59
%
Index- P/E- EPS (ttm)-0.82 Insider Own14.89% Shs Outstand34.64M Perf Week5.00%
Market Cap63.24M Forward P/E- EPS next Y-0.40 Insider Trans0.10% Shs Float32.04M Perf Month25.37%
Income-28.44M PEG- EPS next Q-0.16 Inst Own33.92% Short Float0.37% Perf Quarter57.01%
Sales48.54M P/S1.30 EPS this Y-31.09% Inst Trans-1.17% Short Ratio2.18 Perf Half Y15.86%
Book/sh0.32 P/B5.27 EPS next Y43.29% ROA-47.34% Short Interest0.12M Perf Year-25.99%
Cash/sh0.74 P/C2.26 EPS next 5Y15.00% ROE-128.15% 52W Range0.97 - 2.80 Perf YTD-35.88%
Dividend Est.- P/FCF- EPS past 5Y-25.84% ROI-57.41% 52W High-40.00% Beta1.27
Dividend TTM- Quick Ratio4.52 Sales past 5Y30.52% Gross Margin23.84% 52W Low73.73% ATR (14)0.18
Dividend Ex-Date- Current Ratio5.46 EPS Y/Y TTM-87.49% Oper. Margin-44.44% RSI (14)56.65 Volatility12.69% 12.11%
Employees252 Debt/Eq3.52 Sales Y/Y TTM-3.49% Profit Margin-58.59% Recom2.50 Target Price3.00
Option/ShortYes / Yes LT Debt/Eq3.49 EPS Q/Q-1.65% Payout- Rel Volume0.62 Prev Close1.69
Sales Surprise0.96% EPS Surprise23.91% Sales Q/Q-4.08% EarningsNov 08 BMO Avg Volume55.02K Price1.68
SMA207.88% SMA5023.49% SMA20020.22% Trades Volume33,846 Change-0.59%
Date Action Analyst Rating Change Price Target Change
Oct-17-24Initiated BTIG Research Neutral
Jul-14-23Initiated Stephens Overweight $8
May-20-22Initiated Lake Street Buy $12
Apr-02-19Reiterated Dougherty & Company Buy $12 → $9
Dec-10-24 10:46PM
Nov-27-24 08:00AM
Nov-12-24 04:05PM
Nov-09-24 06:00AM
Nov-08-24 08:15AM
07:15AM Loading…
07:15AM
07:05AM
07:00AM
Nov-07-24 07:12AM
Oct-25-24 08:00AM
Oct-15-24 01:02PM
Oct-09-24 05:58PM
Oct-03-24 12:00PM
Aug-13-24 08:10AM
Aug-08-24 10:00PM
06:30PM Loading…
06:30PM
05:24PM
04:10PM
04:05PM
Jul-25-24 07:30AM
Jun-26-24 07:30AM
May-13-24 11:15AM
May-09-24 11:57AM
08:20AM
07:16AM
07:05AM
07:00AM
Apr-25-24 07:30AM
Apr-11-24 07:30AM
Mar-22-24 10:42AM
10:25PM Loading…
Mar-21-24 10:25PM
11:53AM
08:15AM
07:11AM
07:00AM
Mar-04-24 07:30AM
Feb-21-24 07:30AM
Jan-22-24 07:30AM
Jan-08-24 07:00AM
Nov-28-23 08:30AM
Nov-10-23 02:08PM
Nov-09-23 08:12AM
07:10AM
07:01AM
07:00AM
Nov-07-23 07:30AM
Oct-26-23 09:40AM
Oct-02-23 07:30AM
Aug-15-23 06:40AM
Aug-11-23 11:33AM
Aug-10-23 05:30PM
04:13PM
04:05PM
Aug-02-23 09:58AM
Jul-06-23 08:48AM
Jun-29-23 04:05PM
Jun-20-23 09:40AM
Jun-14-23 07:30AM
May-16-23 09:40AM
May-11-23 11:42PM
07:10AM
07:00AM
May-05-23 01:31PM
May-02-23 07:30AM
Apr-28-23 07:30AM
Apr-14-23 10:28AM
Apr-05-23 04:05PM
Mar-27-23 06:55AM
Mar-18-23 02:03AM
Mar-17-23 12:27AM
Mar-16-23 07:00AM
Feb-27-23 07:30AM
Feb-23-23 07:47AM
Feb-21-23 07:30AM
Feb-16-23 07:30AM
Feb-09-23 07:30AM
Feb-01-23 07:30AM
Jan-27-23 05:41AM
Jan-25-23 07:30AM
Jan-10-23 07:00AM
Jan-03-23 07:30AM
Nov-22-22 04:05PM
Nov-12-22 07:46AM
Nov-10-22 08:15AM
07:00AM
Oct-20-22 09:33AM
Sep-29-22 07:03AM
Sep-26-22 07:30AM
Sep-13-22 06:15AM
Sep-06-22 07:30AM
Sep-02-22 06:42AM
Aug-11-22 04:05PM
Jul-27-22 04:05PM
Jul-18-22 10:40AM
07:45AM
07:30AM
Jul-11-22 07:14AM
Jul-08-22 03:50PM
Jun-30-22 07:30AM
Jun-28-22 07:30AM
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HILL MATTHEW CChief Financial OfficerAug 13 '24Buy1.135,3366,0307,836Aug 13 06:56 PM